We are live on ! Find out more
EC

Euclidean Capital Portfolio holdings

AUM $392M
1-Year Est. Return 31.85%
This Fund
S&P 500
This Quarter Est. Return
+11.02%
1 Year Est. Return
+31.85%
3 Year Est. Return
+76.27%
5 Year Est. Return
-20.16%
10 Year Est. Return
AUM
$238M
AUM Growth
-$67.7M
Cap. Flow
-$79.9M
Cap. Flow %
-33.57%
Top 10 Hldgs %
100%
Holding
11
New
Increased
1
Reduced
1
Closed

Top Buys

Rank Stock Value
1
VEU icon
Vanguard FTSE All-World ex-US ETF
VEU
+$30.1M

Top Sells

Rank Stock Value
1
INDA icon
iShares MSCI India ETF
INDA
+$110M

Sector Composition

Rank Sector Weight
1 Healthcare 13.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VEU icon
1
Vanguard FTSE All-World ex-US ETF
VEU
$65.6B
$184M 77.31%
2,578,184
+435,500
+20% +$30.1M
INDA icon
2
iShares MSCI India ETF
INDA
$6.83B
$19.2M 8.08%
369,600
-2,055,544
-85% -$110M
ORIC icon
3
Oric Pharmaceuticals
ORIC
$1.11B
$11.9M 4.99%
989,410
FHTX icon
4
Foghorn Therapeutics
FHTX
$305M
$7.7M 3.23%
1,573,761
ALEC icon
5
Alector
ALEC
$167M
$3.87M 1.63%
1,307,858
PMVP icon
6
PMV Pharmaceuticals
PMVP
$71.5M
$3.68M 1.55%
2,627,643
SPY icon
7
State Street SPDR S&P 500 ETF Trust
SPY
$782B
$2.73M 1.15%
4,104
RAPT
8
DELISTED
RAPT Therapeutics
RAPT
$2.12M 0.89%
82,234
TNYA icon
9
Tenaya Therapeutics
TNYA
$177M
$1.65M 0.69%
1,015,705
SRZN icon
10
Surrozen
SRZN
$255M
$1.13M 0.47%
87,696
SRZNW icon
11
Surrozen Inc Warrant
SRZNW
$3.42K ﹤0.01%
170,833

Similar funds

Euclidean Capital's Q3 2025 Portfolio in Review

As of Q3 2025, Euclidean Capital held 11 positions worth $238M, down 22% from $306M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Euclidean Capital withdrew a net $79.9M in Q3 2025, reducing 1 holding. Its largest reduction was iShares MSCI India ETF, cutting an estimated $110M.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 7.9% a quarter earlier.

Against the trend, Euclidean Capital added an estimated $30.1M to Vanguard FTSE All-World ex-US ETF.

  • Euclidean Capital added most to Vanguard FTSE All-World ex-US ETF in Q3 2025, an estimated $30.1M increase.
  • Euclidean Capital's biggest Q3 2025 reduction was iShares MSCI India ETF, cutting an estimated $110M.
  • Euclidean Capital's ten largest holdings make up 100% of its $238M portfolio in Q3 2025.
  • Euclidean Capital opened 0 new positions and closed 0 in Q3 2025.
  • Euclidean Capital's portfolio value fell 22% quarter-over-quarter to $238M.

Based on Euclidean Capital's 13F filing for Q3 2025, filed 14 Nov 2025.